tiprankstipranks
Tourmaline Bio announces first patient dosed in Phase 2 TRANQUILITY trial
PremiumThe FlyTourmaline Bio announces first patient dosed in Phase 2 TRANQUILITY trial
2M ago
Tourmaline Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights
PremiumPress Releases
Tourmaline Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights
2M ago
Tourmaline Bio reports Q1 EPS (55c), consensus (67c)
PremiumThe Fly
Tourmaline Bio reports Q1 EPS (55c), consensus (67c)
2M ago
Tourmaline Bio might see weakness today after Roche MG data, says Truist
PremiumThe FlyTourmaline Bio might see weakness today after Roche MG data, says Truist
3M ago
Tourmaline Bio sinks after Chugai myasthenia gravis study failure
PremiumThe Fly
Tourmaline Bio sinks after Chugai myasthenia gravis study failure
3M ago
Tourmaline Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
PremiumPress Releases
Tourmaline Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
4M ago
Tourmaline Bio management to meet with Piper Sandler
PremiumThe FlyTourmaline Bio management to meet with Piper Sandler
5M ago
Tourmaline Bio Announces Closing of $172.5 Million Public Offering of Common Stock, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
PremiumPress Releases
Tourmaline Bio Announces Closing of $172.5 Million Public Offering of Common Stock, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
5M ago
Tourmaline Bio Secures $172.5M from Share Offering
PremiumMarket News
Tourmaline Bio Secures $172.5M from Share Offering
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100